Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

BIIB:US

429.870 USD 0.940 0.22%

As of 20:10:00 ET on 03/27/2015.

Company Profile for Biogen Inc (BIIB)

Biogen Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.

Contact Information

Biogen Inc

225 Binney Street
Cambridge, MA 02142
United States
Phone: 781-464-2000

Key Executives for Biogen Inc (BIIB)

George A ScangosChief Executive OfficerSusan H AlexanderExec VP/Chief Legal Ofcr/Secy
Paul J ClancyExec VP:Finance/CFOAdriana Karaboutis "Andi"Exec VP:Tech & Bus Solutions
Stephen H Holtzman "Steve"Exec VP:Corporate DevelopmentDouglas Edward Williams "Doug"Exec VP:Research & Dev
Stuart A Kingsley "Tony"Exec VP:Global Commercial OpsJohn G CoxExec VP:Pharmaceutical
Kenneth Di PietroExec VP:Human ResourcesAdam M KoppelSenior VP/Chief Strategy Ofcr
Alfred W Sandrock JrSenior VP/Chief Medical OfcrSpyros Artavanis-TsakonasSenior VP/Chief Scientific Ofcr
Gregory F CovinoVP:Finance/Chief Acctg OfcrKaren JewellInvestor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil